UPR Stock Overview
Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally.
Snowflake Score | |
---|---|
Valuation | 6/6 |
Future Growth | 2/6 |
Past Performance | 2/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
Uniphar plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €2.24 |
52 Week High | €3.00 |
52 Week Low | €1.78 |
Beta | 0.76 |
1 Month Change | -3.45% |
3 Month Change | 2.28% |
1 Year Change | -12.50% |
3 Year Change | -10.40% |
5 Year Change | n/a |
Change since IPO | 132.71% |
Recent News & Updates
Recent updates
Shareholder Returns
UPR | GB Healthcare | GB Market | |
---|---|---|---|
7D | -5.9% | 1.3% | -0.7% |
1Y | -12.5% | -28.0% | -1.8% |
Return vs Industry: UPR exceeded the UK Healthcare industry which returned -28.3% over the past year.
Return vs Market: UPR underperformed the UK Market which returned -2.4% over the past year.
Price Volatility
UPR volatility | |
---|---|
UPR Average Weekly Movement | 4.1% |
Healthcare Industry Average Movement | 7.4% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.5% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: UPR has not had significant price volatility in the past 3 months.
Volatility Over Time: UPR's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1967 | 3,000 | Ger Rabbette | www.uniphar.ie |
Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally. The company operates through three divisions: Medtech, Pharma, and Supply Chain & Retail. The Medtech division offers outsourced sales; and marketing, distribution, and support services to medical device manufacturers.
Uniphar plc Fundamentals Summary
UPR fundamental statistics | |
---|---|
Market cap | UK£609.82m |
Earnings (TTM) | UK£38.35m |
Revenue (TTM) | UK£2.18b |
15.9x
P/E Ratio0.3x
P/S RatioIs UPR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
UPR income statement (TTM) | |
---|---|
Revenue | €2.55b |
Cost of Revenue | €2.16b |
Gross Profit | €389.98m |
Other Expenses | €345.17m |
Earnings | €44.82m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.16 |
Gross Margin | 15.28% |
Net Profit Margin | 1.76% |
Debt/Equity Ratio | 70.7% |
How did UPR perform over the long term?
See historical performance and comparisonDividends
0.7%
Current Dividend Yield11%
Payout RatioDoes UPR pay a reliable dividends?
See UPR dividend history and benchmarksUniphar dividend dates | |
---|---|
Ex Dividend Date | Apr 18 2024 |
Dividend Pay Date | May 14 2024 |
Days until Ex dividend | 1 day |
Days until Dividend pay date | 25 days |
Does UPR pay a reliable dividends?
See UPR dividend history and benchmarks